Addressing Gram-Negative Infections With Further Insights From Cefiderocol's PROVE Study
May 5th 2025Sean Nguyen PharmD, BCIDP, medical director, Shionogi, delves into the European cohort portion of the study and offers further information from the trial and some of its bigger clinical ramifications.
NFID Finds Nearly Half of US Adults Admit to Not Washing Their Hands at Key Moments
May 5th 2025The National Foundation for Infectious Diseases (NFID) released its 2025 NFID State of Handwashing Report and found that many US adults forget or choose not to wash their hands at key times when germs can easily spread.
Prompts in Computerized Order Entry Improve Antimicrobial Treatment for Skin, Soft Tissue Infections
May 4th 2025The INSPIRE 3 trial demonstrates that computerized order entry recommendation prompts can reduce empiric use of broad-spectrum antibiotics in favor of targeted treatment for skin and soft tissue infections.
New Insights Into Fungal Infections, Including Resistance, Mortality, and Environmental Risks
April 29th 2025The latest fungal-focused edition of the Centers for Disease Control and Prevention’s journal Emerging Infectious Diseases explores the global spread of antifungal resistance, rising cases of Aspergillus infections, and the detection of Histoplasma.